Cagri Reta Dual Injection Pen Kit

Advanced Retatrutide & Cagrilintide Research Pen System

The Cagri Reta Dual Injection Pen Kit combines Retatrutide 40mg and Cagrilintide 4mg in a convenient two-pen format designed for research applications involving metabolic regulation, appetite signaling, and weight management mechanisms. This innovative combination brings together Retatrutide, a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways, with Cagrilintide, a long-acting amylin analogue studied for its effects on satiety and energy balance.

Each kit includes one Retatrutide 40mg injection pen and one Cagrilintide 4mg injection pen, allowing researchers to investigate complementary metabolic pathways within advanced study protocols. The Retatrutide pen offers adjustable dosing increments of 2.5mg, 5mg, 7.5mg, and 10mg, while the Cagrilintide pen provides precise dosing options of 0.25mg, 0.5mg, 0.75mg, and 1mg.

Developed for laboratory and research use, the Cagri Reta Kit supports studies focused on appetite suppression, body weight regulation, metabolic health, glucose homeostasis, and hormone signaling. The complete package contains two prefilled pens, twelve disposable needles, and a detailed instruction booklet. Both formulations are designed for once-weekly administration on the same scheduled day, providing consistency for long-term research protocols.

Researchers across Europe are increasingly exploring Retatrutide and Cagrilintide combinations due to their potential to target multiple biological pathways associated with weight management, satiety, and metabolic function. The Cagri Reta Dual Injection Pen Kit offers a practical solution for advanced peptide and metabolic research programs.